Member Info for seethreeIPO

Yep, been there, when I bought in to Avacta as a long term play for the therapeutics arm through my trading account rather than my ISA, in December 2020!!! Imagine my pain when HL said "due to covid we no longer offer bed and ISA" a few months later, at the time they announced the LFD, and my initial £15K was worth multiples of that! Having said that....paying tax on profit is better than paying no tax on a lost opportunity or worse, a loss!

Absolultey agree tom, I was thinking that if I valued the company at a measly $10 Billion nobody could ever accuse me of being a ramper! :-)

With the 'war chest' Avacta would have at their finger tips, some will be looking for Avacta to be the acquirer rather than be acquired. They would have a significant opportunity to consolidate the chemo market under the 'precision' technology banner.

With the amount of issued capital in PI hands being so high, it would make a very interesting vote! :-)

However, the management team and other major shareholders would be worth in the hundreds of millions before it got to take over time, you may well find that they'd be happy to keep ownership of a technology they can license out for the rest of their days, and that of their kids, dual list on London main exchange and NASDAQ and we'd have an astronomical share price.

Those of us with large holdings would be happy to sit and take the dividends at 6 figures a year forever! :-)

Agree BITL - Precision chemistry could potentially be applied to all chemo drugs that currently compose the $56 Billion per annum market. At that point even the drug companies that own rights to new chemo treatments would want to licence the technology and apply to their IP further increasing the revenue generating lifetime. Honestly.....it's about as exciting as an opportunity gets.

Treble is extremely conservative, we'd be staring down the barrel at a cure for all cancers treated with Doxorubicin and a route to precision chemistry being used across multiple other chemo drugs. Overnight we'd be looking a complete replacement of the current Doxorubicin market, which is already well over $1Billion per yer. On a conservative 10x valuation the company would be worth in excess of $10 Billion for AVA6K on it's own, and a pipeline of future candidates.

Alastair has called this a 'chemo warhead' and I think that's a great moniker in many ways, this would literally go off like a bomb, and I think that multiples in excess of 15 times todays share price is much more likely. So I believe we'd be looking at 1000p + per share

Just spat out my tea!! :-)

sdon, that's just not how it works with multi-billion technology, they buy the company, send their scientists over here to learn how it's done and then eventually transfer the 'engineering' over to China. Other technologies are easy to copy when you don't have to go through clinical trials to market them globally, with a drug like this even if they did manage to copy it they would not get regulatory approval to sell it anywhere other than China.

Wyn, some logic there but TA does not tell you "what is MOST likely to happen" it tells you what might be statistically MORE likely to happen....otherwise if it were always telling you what is most likely to happen it would be impossible to lose over a diverse portfolio....which as we all know is simply not the case.

Oh god...please don't tell me that plonker 'Joe Hond' from Twitter has gotten in here?

China very much do respect IP, in fact 5 years ago I was on a foreign office ‘mission’ in Beijing and for the first time ever China had brought more IP claims to court than the rest of the world had brought against them! They don’t tend to steal tech anymore they tend to buy the company!

So true! Complete spunknugget that one!

GLA today folks, exciting times.

It think it was a wholly unfair comment, it's utterly insulting to twats!

The Doxorubicin market it worth over a $1 Billion per year now, rising to 1.3 over the next few years even with all it's pitfalls. AVA6K will pretty much replace that market and may even exceed it as the number of suitable patients will increase. Honestly, this development will put Avacta at the forefront of global pharmaceuticals...and that's just Doxorubicin, with other pro drug candidates in the pipe, Avacta are poised to become THE global leader in cancer treatment.

Byyeeeee - funny how the price is now up on opening, but don’t let that stop you going away until August please.

:-) Absolutely, steal at will! In fact, perhaps from now on instead of engaging with the pre-pubescent little parasites we should just respond with 'spunknugget' every time they post the usual detritus?? nothing more, nothing less, just 'spunknugget' and let's see how long it takes them to explode.

None of us that have been around for years on the AVCT board take any notice whatsoever of these new spunknuggets appearing out of nowhere.....silly little boys.

Wow...surely you've got the wrong board....LFT is ABDX......This is all about cancer you moron. These shorting crews really need to so some research before they pay these clowns for posting.

LOL...what would everyone do without the sage words of these people here to save us all from ourselves. Thank you for rescuing us in such altruistic fashion, now off back to the soup kitchen to save some more souls oh great one.

LOL what a 6 post plonker :-) Show me how you can pump a stock 35% in a day please.....someone is stinging.